Although PLK2 belongs to the same family as PLK1, and both kinases are implicated in cell-cycle progression, recent studies as well as our data presented herein suggest that PLK2 may actually be a tumor suppressor that is silenced in many types of cancers, including breast cancer (32–36). Here, PLK2 is linked to breast carcinoma.